Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.
Kriegsmann K et al. Biol Blood Marrow Transplant. 2018 Jan 15. pii: S1083-8791(18)30022-3. doi: 10.1016/j.bbmt.2018.01.007. [Epub ahead of print].

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.
Anderson K et al. J Clin Oncol. 2018 Jan 17:JCO2017766402. doi: 10.1200/JCO.2017.76.6402. [Epub ahead of print].

Re-Vaccination Following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.
Palazzo M et al. Biol Blood Marrow Transplant. 2017 Dec 27. pii: S1083-8791(17)31825-6. doi: 10.1016/j.bbmt.2017.12.795. [Epub ahead of print].

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Leleu X et al. Ann Hematol. 2017 Dec 27. doi: 10.1007/s00277-017-3191-7. [Epub ahead of print].